BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Cell Therapy
    • COVID-19
    • CAR-T
    • Cord Blood
  • Exosomes
  • Interviews
  • News
    • Press Releases
    • Job Posts
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » First Annual State of Regenerative Survey, 2020
State of Regenerative Medicine 2020

First Annual State of Regenerative Survey, 2020

November 25, 2020 By Cade Hildreth (CEO)

The First Annual State of Regenerative Survey, 2020 Edition takes the pulse of Regenerative Medicine in the U.S., addressing controversial topics like Regenerative Medicare Reimbursement, Exosomes, Stem Cell Therapies, and Bad Actors.

2020 has brought chaos to many industries and the Regenerative Marketplace is not the least of them. Many clinics forced to shut down have not reopened while the appointment of a new FDA commissioner with strong opinions about stem cells casts doubts on where the future lies for many Regenerative Practitioners. Historically, conferences have been the hub of information the industry needs for current data and up to date status of the industry. Yet, these conferences have been canceled while Regenerative Covid-19 fast tracks are enabling Regenerative Manufacturers to obtain INDs who otherwise would be waiting for years.

State of Regenerative, 2020 Edition is an in-depth survey sponsored by veteran Regenerative Supply Distributor Dallas Regenerative Solutions. This survey seeks to tap the collective intellect of the dynamic, evolving Medical Art of Regenerative Medicine in the U.S. and provide practitioners a map of the new terrain unfolding before us.

The survey takes less than 10 minutes to complete and covers topics from FDA Regulations to Outcomes, Credentialing, Product Warnings and Credibility. Participants will receive a complimentary copy of the First Annual State of Regenerative Survey, 2020 Edition results for their time taking the survey, as well as exclusive live updates as data becomes available.

The survey may be accessed at the Dallas Regenerative website www.dallasregenerativellc.com by tapping the “Take Survey now” button or you can access the survey directly at www.stateofregenerative.com.

Live updates will be available on LinkedIn at https://www.linkedin.com/company/dallas-regenerative-solutions/.

Take the Survey Now

5 / 5 ( 3 votes )

Filed Under: Press Releases, Stem Cell News

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn

Nanocellect

Marathon Products

Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

Jellagen launches JellaGel™, the first Collagen Type 0 Hydrogel taking on the market leading Extracellular Matrix

Celularity Gx Acquisition

Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy

Helixmith Tadios

Helixmith Announces the Development of Botanical Therapeutic Product for Respiratory Diseases, TADIOS

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2021 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.